what other things could we see from russia? perhaps we ve been waiting for the cyber attacks that haven t happened yet, if peace talks don t go anywhere. there will be a ramping up. this was a political move. you picked private citizens, like hillary clinton at the moment, and didn t pick people who might have much more to do with the current situation in russia. so, you know, i think there will be a ramping up. we may face some cyberattack risk and so on. but the long-term goal has to be limiting putin s leverage over us. we need to make it so when his sanctions are announced, as they were yesterday, they re feeble. we need to make it to his ability to hurt us is limited because we re less entangled with his regime. that s the long-term goal here. basically, disinvesting from russia, ensuring they are isolated for not just months but years and perhaps a generation until they change leadership. press secretary jen psaki laughed at the sanctions from the white house podium yesterday
in a pretty strong position defensively. all right. emeritus professor of war studies at king college of london, lawrence freedman. thank you for being with us. thank you. thank you, clint for being with us. we appreciate you being with us today. david, i want to briefly follow up on something that was just said. we in the united states and in the west, of course, we always focus on the glass that s half empty, what we re not doing. the planes, the 29 old, outdated migs we re not sending to the ukrainians, the boots on the ground, the no-fly zone. that s too much discussion centers around that. as the professor said, the west, the united states getting an extraordinary amount of weapons across the border into ukraine
we might get a little idea of how things will look one step at a time. israel approved a fourth vaccine dose particular those most portable covid-19 ahead of the surge of cases. first the fourth dose is expected to go to people immunocompromised, will the u.s. follow suit will we do so and how quickly will we do so. the u.s. allows a fourth dose for those who are severely immunocompromised but it s relatively modest percentage of the population. the big question do we do this for other groups such as those under the age of 60 or 70 were for healthcare providers. three weeks ago i wrote in the los angeles times the big proponent of offering this to healthcare workers because what s happening based on data out of the college of london for the pfizer biontech vaccine. after you get the third dose it was holding up well versus delta but versus omicron it was starting to decline significantly after three or